Sorafenib and Interferon Alfa in Treating Patients With Metastatic or Unresectable Kidney Cancer
Clinical trial NCT00101114 · COMPLETED
Trial details
- NCT number
- NCT00101114
- Sponsor
- National Cancer Institute (NCI)
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2004-09-01
- Primary completion
- 2006-05-01
- Enrollment
- 55
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.